1.
Nakanuma Y.
Tutorial Review for Understanding of Cholangiopathy.
Int J Hepatol. 2012;2012:1–9.
2.
Lazaridis KN,
LaRusso NF.
The Cholangiopathies.
Mayo Clin Proc.
2015 Jun;90(6):791–800.
3.
Cheung AC,
Lorenzo Pisarello MJ,
LaRusso NF.
Pathobiology of biliary epithelia.
Biochim Biophys Acta - Mol Basis Dis.
2017 Jul;35(5):1256–68.
4.
O’Hara SP,
Tabibian JH,
Splinter PL,
LaRusso NF.
The dynamic biliary epithelia: Molecules,
pathways,
and disease.
J Hepatol.
2013 Mar;58(3):575–82.
5.
Levy,
Angela D. and CAR.
Diseases of the Gallbladder and Bile Ducts.
In: Radiologic-Pathologic Correlations from Head to Toe.
Springer Berlin Heidelberg; 2005.
p.
509–32.
6.
Akhan O,
Karaosmanoǧlu AD,
Ergen B.
Imaging findings in congenital hepatic fibrosis.
Eur J Radiol.
2007;61(1):18–24.
7.
Gomez D,
Rahman S,
Guillou P.
Spontaneous Mesenteric Haematoma: A Diagnostic Challenge.
Ann R Coll Surg Engl.
2006;88(3):269–269.
8.
Seo N,
Kim SY,
Lee SS,
Byun JH,
Kim JH,
Kim HJ,
et al.
Sclerosing Cholangitis: Clinicopathologic Features,
Imaging Spectrum,
and Systemic Approach to Differential Diagnosis.
Korean J Radiol.
2016;17(1):25.
9.
Azizi L,
Raynal M,
Cazejust J,
Ruiz A,
Menu Y,
Arrivé L.
MR Imaging of sclerosing cholangitis.
Clin Res Hepatol Gastroenterol.
2012;36(2):130–8.
10.
Krones E,
Graziadei I,
Trauner M,
Fickert P.
Evolving concepts in primary sclerosing cholangitis.
Liver Int.
2012;32(3):352–69.
11.
Voigtlander T,
Negm AA,
Schneider AS,
Strassburg CP,
Manns MP,
Wedemeyer J,
et al.
Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome.
Endoscopy.
2012;44(11):1055–8.
12.
Leonhardt S,
Veltzke-Schlieker W,
Adler A,
Schott E,
Eurich D,
Faber W,
et al.
Secondary Sclerosing Cholangitis in Critically Ill Patients.
Medicine (Baltimore).
2015;94(49):e2188.
13.
Imam MH,
Talwalkar JA,
Lindor KD.
Secondary Sclerosing Cholangitis.
Pathogenesis,
Diagnosis,
and Management.
Clin Liver Dis.
2013;17(2):269–77.
14.
Abdalian R,
Heathcote EJ.
Sclerosing cholangitis: A focus on secondary causes.
Hepatology.
2006;44(5):1063–74.
15.
Brooling J,
Leal R.
Secondary Sclerosing Cholangitis: a Review of Recent Literature. Curr Gastroenterol Rep.
2017 Sep 27;19(9):44.
16.
Gidwaney NG,
Pawa S,
Das KM.
Pathogenesis and clinical spectrum of primary sclerosing cholangitis.
World J Gastroenterol.
2017;23(14):2459–69.
17.
Horsley-Silva JL,
Carey EJ,
Lindor KD,
Horsley-Silva JL,
Carey EJ.
Advances in primary sclerosing cholangitis.
www.thelancet.com Lancet Gastroenterol Hepatol.
2016;1(1):68–77.